Age-related defects in erythrocyte 2,3-diphosphoglycerate metabolism in dementia

Aging and Disease

Volumn 4, Issue 5, 2013, Pages 244-255

  Kaminsky, Yury G ^a   Prakash Reddy, V ^b   Ashraf, Ghulam Md ^c   Ahmad, Ausaf ^d   Benberin, Valery V ^e   Kosenko, Elena A ^a,f   Aliev, Gjumrakch ^g,h  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d AMITY UNIVERSITY   (India)

^e Medical Center of the Administration of the President of the Republic of Kazakhstan   (Kazakhstan)

^f PUSHCHINO STATE UNIVERSITY   (Russian Federation)

^g GALLY International Biomedical Research Consulting LLC   (United States)

^h University of Atlanta   (United States)

Author keywords

2,3 diphosphoglycerate; Erythrocyte; Glycolysis; Late onset Alzheimer disease; Non Alzheimer's dementia; Oxygen affinity of hemoglobin

Indexed keywords

EID: 84896700209     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2013.0400244     Document Type: Article

References (50)

1. Bassil N and Mollaei C (2012). Alzheimer's dementia: a brief review. Journal medical libanais, 60: 192-199.
2. Qiu C (2009) Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues in Clinical Neuroscience, 11: 111-128
3. Etcheberrigaray R and Ibarreta D (2001). Ionic channels and second messenger alterations in Alzheimer's disease. Relevance of studies in nonneuronal cells. Rev Neurol, 33: 740-749
4. Blass JP, Hanin I, Barclay L, Kopp U and Reding MJ (1985). Red blood cell abnormalities in Alzheimer disease. J Am Geriatr Soc, 33: 401-405
5. Gibson GE and Huang HM (2002). Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Front Biosc, 7: d1007-1015
6. Markesbery WR, Leung PK and Butterfield DA (1980). Spin label and biochemical studies of erythrocyte membranes in Alzheimer's disease. J Neurol Sci, 45: 323-330
7. Benesch R and Benesch RE (1967). The effect of organic phosphates from the human erythrocyte on the allosteric properti es of hemoglobin. Biochem Biophys Res Commun, 26: 162-167
8. Chang CY, Liang HJ, Chow SY, Chen SM and Liu DZ (2007). Hemorheological mechanisms in Alzheimer's disease. Microcirculation, 14: 627-634
9. Mohanty JG, Eckley DM, Williamson JD, Launer LJ and Rifkind JM (2008). Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv Exp Med Biol, 614: 29-35
10. McKhann G, Drachman D, Folstain M, Katzman R, Price D and Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology, 34: 939-944
11. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G and Berg L (1991). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41: 479-486
12. Beutler E, Blume KG, Kaplan JC, Lohr GW, Ramot B and Valentine WN (1977). International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol, 35: 331-340
13. Kaminsky Y, Suslikov A and Kosenko E (2010). Specific and pronounced impacts of lisinopril and lisinopril plus simvastatin on erythrocyte antioxidant enzymes. J Clin Pharmacol, 50: 180-187
14. Kosenko EA, Solomadin IN, Marov NV, Venediktova NI, Pogosyan AS and Kaminskii IuG (2008). Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide A{cyrillic}beta25-35 to erythrocytes. Russ J Bioorg Chem, 34: 586-592
15. Beutler E (1986). Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Kuhl W. Characteristics and significance of the reverse glucose-6-phosphate dehydrogenase reaction. J Lab Clin Med, 107: 502-507
16. Calvin MC, Blouquit Y, Garel MC, Prehu MO, Cohen-Solal M, Rosa and Rosa R (1990). Human bisphosphoglycerate mutase expressed in E. coli: purification, characterization and structure studies. Biochimie, 72: 337-343
17. Kaminsky Y, Poghosyan A, Tikhonova L, Palacios HH, Kamal MA, Kosenko E and Aliev G (2012). Glycolytic and proteolytic metabolism in erythrocytes from elderly and demented patients. Am J Neuroprotect Neuroregener, 4: 73-77
18. Norby JG (1988). Coupled assay of Na+,K+-ATPase activity. Methods Enzymol, 156: 116-119.
19. Lowry OH, Rosenbrough NJ, Farr A and Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193: 265-275
20. Czok R, Lamprecht W (1974). Pyruvate, phosphoenolpyruvate and D-glycerate. In: Bergmeyer HU (ed) Methods of Enzymatic Analysis, vol. 3. Academic Press, New York, 1988 pp. 1446-1451
21. Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AS and Kaminsky YG (2012). Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. CNS Neurol Disord Drug Targets, 11: 926-932
22. Katzman R (1986). Alzheimer's disease. N Engl J Med, 314: 964-973
23. Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME and Morales L (2009). Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. Int J Biochem Cell Biol, 41: 1989-2004
24. Aliev G (2013). The Role of Oxidative Stress, Mitochondria Failure, and Cellular Hypoperfusion in the Context of Alzheimer Disease: Past, Present and Future". Monograph Book: Nova Science Publishers Inc, New York, ISBN: 978-1-61942-878-2. PP. 1-426
25. Hoyer S (1996). Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol Scand Supp, 165: 18-24
26. Marcus DL and Freedman ML (1997). Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease. Ann NY Acad Sci, 826: 248-253
27. Marcus DL, de Leon MJ, Goldman J, Logan J, Christman DR, Wolf AP, Fowler JS, Hunter K, Tsai J, Pearson J and Freedman ML (1989). Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol, 26: 91-94
28. Meier-Ruge W, Iwangoff P and Reichlmeier K (1984). Neurochemical enzyme changes in Alzheimer's and Pick's disease. Arch Gerontol Geriatr, 3: 161-165
29. Perry EK, Perry RH, Tomlinson BE, Blessed G and Gibson PH (1980). Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci Lett, 18: 105110
30. Ajmani RS, Metter EJ, Jaykumar R, Ingram DK, Spangler EL, Abugo OO and Rifkind JM (2000). Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function. Neurobiol Aging, 21: 257-269
31. Aliev G, Li Y, Palacios HH and Obrenovich ME (2011). Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Pat Cardiovasc Drug Discov, 6: 222-241
32. Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA and Perry G (2008). Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: Implication in the pathogenesis of Alzheimer's disease. Vasc Health Risk Manag, 4: 721-730
33. Bogatskaia LN and Pisaruk AV (1987). Mechanism of changes in the rate of glycolysis and levels of ATP and 2,3-diphosphoglycerate in human erythrocytes during aging. Ukr Biokhim Zh, 59: 81-83
34. Bogatskaia LN, Korkushko OV and Pisaruk AV (1986). Age-related changes in glycolysis and levels of modulators of oxygen transport function of hemoglobin in human erythrocytes. Ukr Biokhim Zh, 58: 4145
35. Kawamoto EM, Munhoz CD, Glezer I, Bahia VS, Caramelli P, Nitrini R, Gorjão R, Curi R, Scavone C and Marcourakis T (2005). Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease. Neurobiol Aging, 26: 857-864
36. Waypa GB, Marks JD, Mack MM, Boriboun C, Mungai PT and Schumacker PT (2002). Mitochondrial reactive oxygen species trigger calcium increases during hypoxia in pulmonary arterial myocytes. Circ Res, 91: 719-726
37. Cheah KS and Chance B (1970). The oxidase systems of A scaris-muscle mitochondria. Biochim Biophys Acta, 223: 55-60.
38. Aliev G, Smith MA, de la Torre JC and Perry G (2004). Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion, 4: 649-663
39. Mansfield KD, Simon MC and Keith B (2004). Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol, 97: 1358-1366
40. Agani FH, Pichiule P, Chavez JC and LaManna JC (2000). The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J Biol Chem, 275: 35863-35867
41. Pearlstein DP, Ali MH, Mungai PT, Hynes KL, Gewertz BL and Schumacker PT (2002). Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia. Arterioscler Thromb Vasc Biol, 22: 566-573
42. Duranteau J, Chandel NS, Kulisz A, Shao Z and Schumacker PT (1998). Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem, 273: 11619-11624
43. Bonda DJ, Wang X, Gustaw-Rothenberg KA, Perry G, Smith MA and Zhu X (2009). Mitochondrial drugs for Alzheimer disease. Pharmaceuticals, 2: 287-298
44. Abugo OO and Rifkind JM (1994). Oxidation of hemoglobin and the enhancement produced by nitroblue tetrazolium. J Biol Chem, 269: 24845-24853
45. Kiefmann R, Rifkind JM, Nagababu E and Bhattacharya J (2008). Red blood cells induce hypoxic lung inflammation. Blood, 111: 5205-5214
46. Alexandrova ML and Bochev G (2009). Reduced extracellular phagocyte oxidative activity, antioxidant level changes and increased oxidative damage in healthy human blood as a function of age. Age, 31: 99-107
47. Rybka J, Kupczyk D, Kedziora-Kornatowska K, Pawluk H, Czuczejko J, Szewczyk-Golec K, Kozakiewicz M, Antonioli M, Carvalho LA and Kedziora J (2011). Age-related changes in an antioxidant defense system in elderly patients with essential hypertension compared with healthy controls. Redox Rep, 16: 71-77
48. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M and Pourmotabbed T (2008). Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Clin Biochem, 41: 932-936
49. Sulkava R, Nordberg UR, Erkinjuntti T and Westermarck T (1986). Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer's disease and other dementias. Acta Neurol Scand, 73: 487-489
50. Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J and Aliev G (2011). Antioxidants in health, disease and aging. CNS Neurol Disord Drug Targets, 10: 192-207